Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Farwell Wildon | Chief Medical Officer | Mar 12 '24 | Sale | 25.58 | 1,030 | 26,347 | 150,560 | Mar 12 09:58 PM | Brumm Joshua T | CEO & President | Mar 11 '24 | Option Exercise | 5.54 | 50,000 | 277,000 | 604,385 | Mar 12 09:56 PM | McNeill Jonathan | Chief Business Officer | Mar 11 '24 | Option Exercise | 5.54 | 17,825 | 98,750 | 159,009 | Mar 13 06:04 AM | Brumm Joshua T | CEO & President | Mar 11 '24 | Sale | 25.67 | 66,387 | 1,704,142 | 537,998 | Mar 12 09:56 PM | McNeill Jonathan | Chief Business Officer | Mar 11 '24 | Sale | 25.50 | 19,601 | 499,842 | 139,408 | Mar 13 06:04 AM | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 11 '24 | Sale | 25.28 | 2,672 | 67,542 | 119,283 | Mar 12 09:57 PM | HIGH SUSANNA GATTI | Chief Operating Officer | Mar 11 '24 | Sale | 25.70 | 2,292 | 58,904 | 156,800 | Mar 13 06:04 AM | Beskrovnaya Oxana | Chief Scientific Officer | Mar 11 '24 | Sale | 25.70 | 2,081 | 53,482 | 152,352 | Mar 12 09:42 PM | Farwell Wildon | Chief Medical Officer | Mar 11 '24 | Sale | 25.70 | 1,585 | 40,734 | 151,590 | Mar 12 09:58 PM | Brumm Joshua T | CEO & President | Mar 08 '24 | Option Exercise | 5.54 | 363,343 | 2,012,920 | 917,728 | Mar 12 09:56 PM | McNeill Jonathan | Chief Business Officer | Mar 08 '24 | Option Exercise | 5.54 | 90,000 | 498,600 | 231,184 | Mar 13 06:04 AM | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 08 '24 | Option Exercise | 5.54 | 86,252 | 477,836 | 208,207 | Mar 12 09:57 PM | Brumm Joshua T | CEO & President | Mar 08 '24 | Sale | 25.93 | 363,343 | 9,421,634 | 554,385 | Mar 12 09:56 PM | McNeill Jonathan | Chief Business Officer | Mar 08 '24 | Sale | 26.24 | 90,000 | 2,361,531 | 141,184 | Mar 13 06:04 AM | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 08 '24 | Sale | 26.22 | 86,252 | 2,261,465 | 121,955 | Mar 12 09:57 PM | HIGH SUSANNA GATTI | Chief Operating Officer | Mar 08 '24 | Sale | 26.67 | 27,199 | 725,344 | 159,092 | Mar 13 06:04 AM | Farwell Wildon | Chief Medical Officer | Mar 07 '24 | Sale | 25.86 | 9,921 | 256,585 | 153,175 | Mar 11 09:52 PM | Brumm Joshua T | CEO & President | Mar 07 '24 | Sale | 25.85 | 9,086 | 234,873 | 554,385 | Mar 11 09:57 PM | McNeill Jonathan | Chief Business Officer | Mar 07 '24 | Sale | 25.85 | 2,434 | 62,919 | 141,184 | Mar 11 09:50 PM | Beskrovnaya Oxana | Chief Scientific Officer | Mar 07 '24 | Sale | 25.85 | 2,373 | 61,342 | 154,433 | Mar 11 09:56 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 07 '24 | Sale | 25.85 | 2,273 | 58,757 | 121,955 | Mar 11 09:45 PM | HIGH SUSANNA GATTI | Chief Operating Officer | Mar 07 '24 | Sale | 25.85 | 1,591 | 41,127 | 186,291 | Mar 11 09:56 PM | Brumm Joshua T | CEO & President | Mar 01 '24 | Option Exercise | 5.54 | 94,480 | 523,419 | 657,951 | Mar 01 09:38 PM | McNeill Jonathan | Chief Business Officer | Mar 01 '24 | Option Exercise | 0.73 | 24,260 | 17,710 | 167,878 | Mar 01 09:37 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 01 '24 | Option Exercise | 1.03 | 9,311 | 9,590 | 133,539 | Mar 01 09:37 PM | Brumm Joshua T | CEO & President | Mar 01 '24 | Sale | 29.04 | 94,480 | 2,743,718 | 563,471 | Mar 01 09:38 PM | Rhodes Jason P | Director | Mar 01 '24 | Sale | 30.05 | 46,534 | 1,398,347 | 847,388 | Mar 05 05:08 PM | Atlas Venture Opportunity Fund | 10% Owner | Mar 01 '24 | Sale | 30.05 | 29,435 | 884,522 | 1,458,691 | Mar 05 05:07 PM | McNeill Jonathan | Chief Business Officer | Mar 01 '24 | Sale | 28.63 | 24,260 | 694,495 | 143,618 | Mar 01 09:37 PM | Atlas Venture Opportunity Fund | 10% Owner | Mar 01 '24 | Sale | 30.05 | 17,099 | 513,825 | 847,388 | Mar 05 05:07 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 01 '24 | Sale | 28.25 | 9,311 | 262,999 | 124,228 | Mar 01 09:37 PM | Brumm Joshua T | CEO & President | Feb 29 '24 | Option Exercise | 5.54 | 5,520 | 30,581 | 568,991 | Mar 01 09:38 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Feb 29 '24 | Option Exercise | 1.03 | 3,429 | 3,532 | 127,657 | Mar 01 09:37 PM | McNeill Jonathan | Chief Business Officer | Feb 29 '24 | Option Exercise | 0.73 | 4,268 | 3,116 | 147,886 | Mar 01 09:37 PM | Brumm Joshua T | CEO & President | Feb 29 '24 | Sale | 27.50 | 5,520 | 151,800 | 563,471 | Mar 01 09:38 PM | McNeill Jonathan | Chief Business Officer | Feb 29 '24 | Sale | 27.50 | 4,268 | 117,370 | 143,618 | Mar 01 09:37 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Feb 29 '24 | Sale | 27.50 | 3,429 | 94,298 | 124,228 | Mar 01 09:37 PM | Rhodes Jason P | Director | Feb 28 '24 | Sale | 24.84 | 190,920 | 4,741,804 | 864,487 | Feb 28 07:15 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 28 '24 | Sale | 24.84 | 154,674 | 3,841,576 | 5,698,091 | Feb 28 07:13 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 28 '24 | Sale | 24.84 | 36,246 | 900,228 | 864,487 | Feb 28 07:13 PM | Rhodes Jason P | Director | Feb 27 '24 | Sale | 24.41 | 368,699 | 8,998,426 | 877,806 | Feb 28 07:15 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 27 '24 | Sale | 24.41 | 298,702 | 7,290,088 | 5,852,765 | Feb 28 07:13 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 27 '24 | Sale | 24.41 | 69,997 | 1,708,338 | 877,806 | Feb 28 07:13 PM | Rhodes Jason P | Director | Feb 26 '24 | Sale | 23.72 | 248,219 | 5,886,673 | 903,527 | Feb 28 07:15 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 26 '24 | Sale | 23.72 | 201,095 | 4,769,096 | 6,151,467 | Feb 28 07:13 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 26 '24 | Sale | 23.72 | 47,124 | 1,117,577 | 903,527 | Feb 28 07:13 PM | Rhodes Jason P | Director | Feb 23 '24 | Sale | 22.70 | 196,928 | 4,470,266 | 920,843 | Feb 23 06:59 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 23 '24 | Sale | 22.70 | 159,542 | 3,621,603 | 6,352,562 | Feb 23 06:58 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 23 '24 | Sale | 22.70 | 37,386 | 848,662 | 920,843 | Feb 23 06:58 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 22 '24 | Sale | 22.66 | 119,360 | 2,704,698 | 6,512,104 | Feb 23 06:58 PM | Rhodes Jason P | Director | Feb 22 '24 | Sale | 22.66 | 119,360 | 2,704,698 | 6,512,104 | Feb 23 06:59 PM | Rhodes Jason P | Director | Feb 21 '24 | Sale | 22.57 | 184,501 | 4,164,817 | 6,631,464 | Feb 23 06:59 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 21 '24 | Sale | 22.57 | 184,501 | 4,164,817 | 6,631,464 | Feb 23 06:58 PM | Rhodes Jason P | Director | Feb 20 '24 | Sale | 22.72 | 169,539 | 3,852,653 | 6,815,965 | Feb 20 06:36 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 20 '24 | Sale | 22.72 | 169,539 | 3,852,653 | 6,815,965 | Feb 20 06:35 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 16 '24 | Sale | 23.14 | 162,707 | 3,765,040 | 6,985,504 | Feb 20 06:35 PM | Rhodes Jason P | Director | Feb 16 '24 | Sale | 23.14 | 162,707 | 3,765,040 | 6,985,504 | Feb 20 06:36 PM | Rhodes Jason P | Director | Feb 15 '24 | Sale | 23.89 | 177,906 | 4,249,600 | 7,148,211 | Feb 20 06:36 PM | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 15 '24 | Sale | 23.89 | 177,906 | 4,249,600 | 7,148,211 | Feb 20 06:35 PM | Farwell Wildon | Chief Medical Officer | Feb 12 '24 | Sale | 25.07 | 5,493 | 137,710 | 163,503 | Feb 14 04:27 PM | McNeill Jonathan | Chief Business Officer | Jan 26 '24 | Option Exercise | 0.73 | 20,000 | 14,600 | 163,618 | Jan 26 07:48 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Jan 26 '24 | Option Exercise | 1.03 | 13,000 | 13,390 | 137,228 | Jan 26 07:47 PM | McNeill Jonathan | Chief Business Officer | Jan 26 '24 | Sale | 24.53 | 20,000 | 490,510 | 143,618 | Jan 26 07:48 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Jan 26 '24 | Sale | 24.34 | 13,000 | 316,420 | 124,228 | Jan 26 07:47 PM | Farwell Wildon | Chief Medical Officer | Jan 26 '24 | Sale | 25.00 | 100 | 2,500 | 168,996 | Jan 26 07:49 PM | Kersten Dirk | Director | Jan 09 '24 | Buy | 17.50 | 1,714,285 | 29,999,988 | 6,416,793 | Jan 11 04:31 PM | Brumm Joshua T | CEO & President | Jan 04 '24 | Option Exercise | 5.16 | 218,536 | 1,127,092 | 803,507 | Jan 04 09:49 PM | Beskrovnaya Oxana | Chief Scientific Officer | Jan 04 '24 | Option Exercise | 1.03 | 22,674 | 23,354 | 199,259 | Jan 04 09:48 PM | McNeill Jonathan | Chief Business Officer | Jan 04 '24 | Option Exercise | 0.73 | 2,009 | 1,467 | 145,627 | Jan 04 09:47 PM | Brumm Joshua T | CEO & President | Jan 04 '24 | Sale | 18.51 | 218,536 | 4,045,958 | 584,971 | Jan 04 09:49 PM | Beskrovnaya Oxana | Chief Scientific Officer | Jan 04 '24 | Sale | 18.13 | 42,453 | 769,673 | 156,806 | Jan 04 09:48 PM | McNeill Jonathan | Chief Business Officer | Jan 04 '24 | Sale | 18.04 | 2,009 | 36,242 | 143,618 | Jan 04 09:47 PM | Brumm Joshua T | CEO & President | Jan 03 '24 | Option Exercise | 1.03 | 51,183 | 52,718 | 636,154 | Jan 04 09:49 PM | Beskrovnaya Oxana | Chief Scientific Officer | Jan 03 '24 | Option Exercise | 1.03 | 45,326 | 46,686 | 221,911 | Jan 04 09:48 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Jan 03 '24 | Option Exercise | 1.03 | 13,000 | 13,390 | 137,228 | Jan 04 09:46 PM | McNeill Jonathan | Chief Business Officer | Jan 03 '24 | Option Exercise | 0.73 | 17,991 | 13,133 | 161,609 | Jan 04 09:47 PM | Brumm Joshua T | CEO & President | Jan 03 '24 | Sale | 19.28 | 51,183 | 986,957 | 584,971 | Jan 04 09:49 PM | Beskrovnaya Oxana | Chief Scientific Officer | Jan 03 '24 | Sale | 18.98 | 45,326 | 860,313 | 176,585 | Jan 04 09:48 PM | McNeill Jonathan | Chief Business Officer | Jan 03 '24 | Sale | 18.74 | 17,991 | 337,062 | 143,618 | Jan 04 09:47 PM | Scalzo Richard William | SVP, Head of Finance & Admin. | Jan 03 '24 | Sale | 18.81 | 13,000 | 244,530 | 124,228 | Jan 04 09:46 PM | McNeill Jonathan | Chief Business Officer | Jan 02 '24 | Sale | 13.10 | 11,900 | 155,890 | 143,618 | Jan 04 09:47 PM | Scalzo Richard William | See Remarks | Dec 14 '23 | Sale | 12.02 | 2,376 | 28,560 | 124,228 | Dec 14 04:59 PM | Farwell Wildon | Chief Medical Officer | Dec 12 '23 | Sale | 10.55 | 978 | 10,318 | 169,096 | Dec 12 05:33 PM | Brumm Joshua T | See Remarks | Dec 11 '23 | Sale | 10.72 | 7,585 | 81,311 | 584,971 | Dec 12 05:33 PM | Farwell Wildon | Chief Medical Officer | Dec 11 '23 | Sale | 10.72 | 1,688 | 18,095 | 170,074 | Dec 12 05:33 PM | HIGH SUSANNA GATTI | Chief Operating Officer | Dec 11 '23 | Sale | 10.72 | 1,616 | 17,324 | 187,882 | Dec 12 05:34 PM | Beskrovnaya Oxana | Chief Scientific Officer | Dec 11 '23 | Sale | 10.72 | 1,467 | 15,726 | 176,585 | Dec 12 05:32 PM | Scalzo Richard William | See Remarks | Dec 11 '23 | Sale | 10.72 | 1,380 | 14,794 | 126,604 | Dec 12 05:35 PM | McNeill Jonathan | Chief Business Officer | Dec 11 '23 | Sale | 10.72 | 1,245 | 13,346 | 155,518 | Dec 12 05:34 PM | Scalzo Richard William | See Remarks | Dec 06 '23 | Sale | 12.01 | 1,872 | 22,483 | 127,984 | Dec 06 06:13 PM | Scalzo Richard William | See Remarks | Dec 04 '23 | Sale | 12.01 | 681 | 8,179 | 129,856 | Dec 06 06:13 PM | HIGH SUSANNA GATTI | Chief Operating Officer | Nov 02 '23 | Sale | 7.40 | 9,939 | 73,549 | 94,605 | Nov 02 05:16 PM | Brumm Joshua T | See Remarks | Sep 18 '23 | Sale | 9.41 | 12,032 | 113,221 | 233,679 | Sep 20 04:47 PM | HIGH SUSANNA GATTI | Chief Operating Officer | Sep 18 '23 | Sale | 9.41 | 2,672 | 25,144 | 104,544 | Sep 20 04:48 PM | Beskrovnaya Oxana | Chief Scientific Officer | Sep 18 '23 | Sale | 9.41 | 1,436 | 13,513 | 84,334 | Sep 20 04:47 PM | Scalzo Richard William | See Remarks | Sep 18 '23 | Sale | 9.41 | 1,290 | 12,139 | 40,795 | Sep 20 04:49 PM | McNeill Jonathan | Chief Business Officer | Sep 18 '23 | Sale | 9.41 | 1,261 | 11,866 | 60,605 | Sep 20 04:49 PM | Brumm Joshua T | See Remarks | Sep 12 '23 | Sale | 10.41 | 7,672 | 79,866 | 245,711 | Sep 13 07:50 PM | Farwell Wildon | Chief Medical Officer | Sep 12 '23 | Sale | 10.41 | 1,707 | 17,770 | 89,250 | Sep 13 07:56 PM | HIGH SUSANNA GATTI | Chief Operating Officer | Sep 12 '23 | Sale | 10.41 | 1,635 | 17,020 | 107,216 | Sep 13 07:51 PM |
|